Revenue Crushes Guidance, But Margins Tell the Real Story
Q2 delivered ₹579.8 Cr revenue (+38.4% YoY, well above prior 23–25% guidance), but EBITDA margins compressed 184 basis points to 6.89% due to commodity price lag. Management cut FY27 EBITDA guidance to 7.5–8% from 8–8.5%, signaling a year of margin recovery, not earnings growth.
₹579.8 Cr
+38.4% YoY
6.89%
−184 bps YoY
7.5–8%
Cut from 8–8.5%
Salzer delivered one of the year's most revealing earnings: a topline beat that masks a margin story. Q2 revenue surged 38.4% YoY to ₹579.8 Cr, far exceeding the prior 23–25% guidance. But EBITDA margin collapsed to 6.89% from 8.73%—a 184 basis point fall. Management's response: cut FY27 EBITDA margin guidance from 8–8.5% to 7.5–8%. The quarter is not about earnings. It's about margin recovery—if it comes.
Where the margin compression came from
Copper, aluminium, and silver prices spiked 40–50% in H1 FY27, compressing the Switchgear division's margin to 8.26% (from ~10% historically). Salzer announced price increases to pass costs through to customers, but the lag is real: announced in Q2, realization expected Q3–Q4. Wire & Cable margins held at 5.05% (cost-plus model protects the division), but Switchgear's commodity exposure dominates the blended result. The company took the full margin hit in Q2; recovery depends on customer order timing in the next two quarters.
Q2 EBITDA margin 6.89% reflects pricing actions against commodity volatility.
EBITDA ₹39.95 Cr / Revenue ₹579.8 Cr = 6.89%; prior Q2 FY26 was 8.73%. Switchgear EBITDA margin 8.26% (at 80% utilization) shows some pricing benefit.
Supported (but compressed)
FY27 revenue guidance ~₹2,100 Cr (~30% growth).
H1 FY27 ₹1,077.79 Cr (25.3% YoY growth); extrapolates to ₹2,150–2,200 Cr FY27 at 25–28% growth, not 30%.
Overstated
Working capital days reduced 16–17 days to 135 from 153.
MD stated reduction of 'around 16 days' H1 FY27; will continue similar pace next 6 months.
Supported
FY27 EBITDA margin target 7.5–8% (from prior 8–8.5%).
Prior call: 8–8.5%. This call: 7.5–8%. Explicit cut acknowledged due to commodity spikes and pricing lag.
Supported (confirmed)
What changed on this call
Three material downgrades: (1) EBITDA margin guidance cut to 7.5–8% FY27 midpoint from prior 8–8.5%. (2) BBMP Bangalore project delayed to Feb 2027 (Q4) from Q3; ₹200 Cr IP, Salzer 49% stake, expected ₹2.25 Cr monthly revenue. (3) Saudi Arabia plant delayed to April 2027 from Sept 2026 due to Middle East geopolitical risk; ₹15 Cr capex, ₹20 Cr Y1 revenue target. One offset: revenue guidance raised to ~₹2,100 Cr FY27 (from ₹1,975–2,025 Cr prior), driven by Q2's 38.4% beat and pricing actions taking hold. But guidance revision underscores a year focused on margin recovery, not earnings growth.
Bull-bear ledger
Revenue growth crushed guidance (+38.4% vs prior 23–25%); pricing power evident.
Switchgear utilization 80%, Wire & Cable 65%; capacity to absorb growth without major capex.
Working capital improving (16-day reduction H1; finance costs as % of sales falling to 2.3–2.4% from 3%).
10-year revenue CAGR 17%; 5-year CAGR 23%; track record of delivery.
EBITDA margin compression severe (184 bps YoY); guidance cut mid-year signals prior lack of buffer.
Margin recovery Q3–Q4 unproven; customer order timing and willingness to absorb full price increases uncertain.
New ventures delayed (BBMP Feb 2027, Saudi April 2027); execution partner risk on both.
Smart meter capex stuck below breakeven; order book weak; minimum ₹25–30 Cr/quarter required.
Debt-to-equity at 0.92x (highest in 4 years); leverage up from commodity inventory buildup; FY28 earnings leverage needed to delever.
Commodity price lag / pricing power crumbles
HIGHQ2 EBITDA 184 bps below prior year. Copper/aluminium/silver spikes 40–50% and lag in customer pass-through extend into Q4. If customer pushback hardens, margin recovery stalls and FY27 guidance (7.5–8%) becomes a floor, not a step.
New venture execution delays compound
MEDIUMBBMP & Saudi both delayed 4–6 months. FY28 guidance (9–10% EBITDA) depends on these ramping. Further delays or market demand weakening could push margin recovery into FY29.
Smart meter breakeven timing extends
MEDIUM₹50 Cr capex invested; minimum ₹25–30 Cr/quarter to breakeven. Order book weak; Tamil Nadu govt tender postponed to Jan–Feb 2027. ROI payback extends, capital opportunity cost rises.
Leverage unwind slower than expected
MEDIUMD/E at 0.92x (highest in 4 years); finance costs up ₹2 Cr YoY. FY28 margin recovery (9–10%) needed to delever. If margins don't recover, leverage persists and constrains capex/M&A for 2–3 years.
How the street is positioned
The stock sits at ₹548.55 (as of 16 Nov 2026), down 66.75% from its all-time high and 19.25% above its 52-week low (₹460–₹809 range). It trades above its 20-day (₹495.93) and 50-day (₹517.8) averages, but below the 200-day (₹589.27), suggesting recent recovery in a longer downtrend. RSI 62.9 is neutral. FII ownership has increased materially: 5.92% in Q2 from 4.51% in Q1, a 141 bps gain—suggesting institutional buyers are taking the view that the stock's 66% drawdown offers value. DII ownership is negligible (0.00%); domestic institutions have not participated. Promoter ownership flat at 37.48%. Volume trend is increasing, consistent with recovering interest. Bulk deals on 9 Nov (AlphaGrep BULK_BUY 1,12,256 @ ₹549.58 / BULK_SELL 1,12,256 @ ₹549.34) are repositioning trades, not insider selling pressure. The market has repriced the stock down; FII accumulation suggests belief that upside is now available below current margins.
The debate
1 · Q3 EBITDA margin realization
Track whether Q3 margin improves toward 7.5%+ as pricing actions flow through customer orders. This is the key proof point. If Q3 margin <7%, the full-year 7.5–8% target is at risk and stock re-rates downward.
2 · BBMP revenue start confirmation
Confirm that BBMP Bangalore project (Feb 2027 expected) is on track. If delayed past Q4, FY28 guidance credibility weakens significantly.
3 · Commodity price stabilization
Monitor copper, aluminium, silver prices on the MCX. If prices remain elevated or rise further, margin recovery is capped. If prices fall >10%, upside surprise to margins possible.
4 · Working capital days trajectory
Confirm that WC days continue to fall (from 135 days current) as commodity inventory normalizes. Stalling WC improvement signals demand softness or pricing lag extension.
Salzer's Q2 is a study in optics vs. substance: the topline beat (38.4%) captures headlines, but the margin story (184 bps YoY compression) is the year. Management has credibly mapped a recovery path (pricing Q3–Q4, FY28 9–10% EBITDA), but the path requires execution on two fronts: customer order timing for price increases to realize, and new ventures (BBMP, Saudi) staying on schedule.
The stock is repriced: down 66% from ATH, trading at a reasonable entry point if the recovery holds. FII accumulation (5.92% from 4.51%) suggests institutional buyers agree. But the next quarter is do-or-die: if Q3 margin improves as guided, the stock has upside. If Q3 disappoints (margin <7%), the stock re-tests the lows.
The number to track from here: Q3 EBITDA margin. Everything else is commentary.
Informational and educational content only. Not investment advice.